Received Feb 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | UNK | — |
patient received 2 doses of Twinrix, one in April and one in May of 2010; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 75-year-old female patient who received HAB (Twinrix adult) for prophylaxis. Previously administered products included Twinrix (received 1st dose in April 2010) and Twinrix (received 2nd dose in May 2010). On an unknown date, the patient received the 3rd dose of Twinrix adult. On an unknown date, an unknown time after receiving Twinrix adult, the patient experienced incomplete course of vaccination (Verbatim: patient received 2 doses of Twinrix, one in April and one in May of 2010). The outcome of the incomplete course of vaccination was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 05-FEB-2025 The pharmacist reported a patient received 2 doses of Twinrix, one in April and one in May of 2010. The pharmacist did not have lot or expiration date of product. The pharmacist stated that he believed it was administered at MD office. Till the time of reporting, the patient did not receive 3rd dose of Twinrix vaccine which led to incomplete course of vaccination.